Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 18, 2006
Issued Date -
N/A
app pub date -
Dec 19, 2002
filing date -
Jan 25, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Certain cells, including types of cancer cells such as lymphomas, are capable of expressing high levels of CD84Hy1. Immunotargeting using CD84Hy1 polypeptides, nucleic acids encoding for CD84Hy1 polypeptides and anti-CD84Hy1 antibodies provides a method of killing or inhibiting that growth of CD84HY1Protein-expressing cancer cells. Methods of immunotherapy and diagnosis of disorders associated with CD84Hy1protein-expressing cells are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully